Healthcare
19 Pharma Stocks to Watch: Top 5 Picks Offer Up to 22% Upside
This 'Data Shots' feature delves into the Indian pharmaceutical sector, highlighting 19 pharma stocks that analysts are keeping an eye on. The analysis identifies top picks with promising upside potential, offering insights for investors tracking the Indian stock market. We look at potential returns from leading companies, offering a snapshot of the pharmaceutical sector analysis. This report aims to provide a clear view on pharma stock upside potential, drawing from expert recommendations and market trends. It's a must-read for anyone interested in the performance of top pharma companies in India, including specific mentions of stocks like Abbott India, Lupin, Biocon, Sun Pharma, and Piramal Pharma.
This 'Data Shots' feature delves into the Indian pharmaceutical sector, highlighting 19 pharma stocks that analysts are keeping an eye on. The analysis identifies top picks with promising upside potential, offering insights for investors tracking the Indian stock market. We look at potential returns from leading companies, offering a snapshot of the pharmaceutical sector analysis. This report aims to provide a clear view on pharma stock upside potential, drawing from expert recommendations and market trends. It's a must-read for anyone interested in the performance of top pharma companies in India, including specific mentions of stocks like Abbott India, Lupin, Biocon, Sun Pharma, and Piramal Pharma.
More in Healthcare
Nifty
Nifty 50 Today: Adani Ent Leads Gains While HDFC Life Falls (25th Aug '26)
- Adani Enterprises led the Nifty 50 gainers with a 3.72% le, followed by Max Health at 2.5%
- Apollo Hospitals gained 2.15%, while IndiGo and Adani Ports rose 2.01% and 1.83%
- HDFC Life was the biggest laggard, falling upto 1.13%, followed by Cipla and ONGC
Healthcare
Manipal Health Bets on Organic Growth After Landmark IPO Launch
- Manipal plans to add nearly 3,000 beds through greenfield and brownfield projects.
- Most IPO proceeds will repay debt, helping the hospital chain become nearly debt free.
- Management says future growth will focus on expansion before pursuing large acquisitions.